real-world efficacy data of rituximab in patients with neuromyelitis optica spectrum disorders

被引：0
|
作者：
Coutinho Thomas, Domingo [1 ]
Martinez Lopez, Yazmin [1 ]
Alcocer Villanueva, Homero [1 ]
Gonzalez Gonzalez, Jose [1 ]
Rivera Lopez, Sarai [1 ]
Corona Vazquez, Teresita [1 ]
Rivas, Veronica [1 ]
Flores Rivera, Jose [1 ]
机构：
[1] Natl Inst Neurol & Neurosurg, Neurol Dept, Demyelinating Disorders Clin, Ciudad De Mexico, Mexico
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P781/3023
引用
收藏
页码：1100 / 1100
页数：1
相关论文
共 50 条
  • [1] real-world safety data of rituximab among mexican patients with neuromyelitis optica spectrum disorders
    Thomas, Domingo Coutinho
    Lopez, Yazmin Martinez
    Villanueva, Homero Alcocer
    Lopez, Sarai Rivera
    Gonzalez, Jose Gonzalez
    Vazquez, Teresita Corona
    Rivas, Veronica
    Rivera, Jose De Jesus Flores
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1127 - 1127
  • [2] The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey
    Uzunkopru, Cihat
    Tutuncu, Melih
    Gunduz, Tuncay
    Gumus, Haluk
    Sen, Sedat
    Demir, Serkan
    Cinar, Bilge Piri
    Ture, Hatice Sabiha
    Uygunoglu, Ugur
    Togrol, Rifat Erdem
    Terzi, Murat
    Kurtuncu, Murat
    Ozakbas, Serkan
    Tutuncu, Mesude
    Beckmann, Yesim
    Siva, Aksel
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (07)
  • [3] Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders
    Novi, Giovanni
    Bovis, Francesca
    Capobianco, Marco
    Frau, Jessica
    Mataluni, Giorgia
    Curti, Erica
    Zuliani, Luigi
    Cavalla, Paola
    Brambilla, Laura
    Annovazzi, Pietro
    Repice, Anna Maria
    Lanzillo, Roberta
    Esposito, Sabrina
    Benedetti, Luana
    Maietta, Ilaria
    Sica, Francesco
    Buttari, Fabio
    Malucchi, Simona
    Fenu, Giuseppe
    Landi, Doriana
    Bosa, Chiara
    Realmuto, Sabrina
    Malentacchi, Maria
    Granella, Franco
    Signori, Alessio
    Bonavita, Simona
    Uccelli, Antonio
    Sormani, Maria Pia
    Nozzolillo, Agostino
    Gallo, Fabio
    Signoriello, Elisabetta
    Clerici, Valentina Torri
    La Gioia, Sara
    Cocco, Eleonora
    Sartori, Arianna
    Rasia, Sarah
    Cordioli, Cinzia
    Barone, Stefania
    Solaro, Claudio
    Nociti, Viviana
    Gobbi, Claudio
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 36
  • [4] Retrospective Observation of Low-Dose Rituximab Treatment in Chinese Patients With Neuromyelitis Optica Spectrum Disorders in a Real-World Setting
    Xiao, Haibing
    Zeng, Wenshuang
    Li, Ling
    Li, Lina
    Cui, Yuzhen
    Wang, Jie
    Ye, Jinhao
    Yang, Qingyan
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [5] A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder
    Xuefen Chen
    Rui Wang
    Rui Li
    Shengfei Hu
    Ziyan Shi
    Hongyu Zhou
    Journal of Neurology, 2025, 272 (3)
  • [6] Efficacy and safety of azathioprine for neuromyelitis optica spectrum disorders: A meta-analysis of real-world studies
    Luo, Daohuang
    Wei, Ran
    Tian, Xin
    Chen, Chaoyang
    Ma, Lingyun
    Li, Min
    Dong, Xiu
    Zhang, Enyao
    Zhou, Ying
    Cui, Yimin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [7] Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in caucasian patients
    Radaelli, M.
    Sangalli, F.
    Moiola, L.
    Rodegher, M.
    Colombo, B.
    Esposito, F.
    Fazio, R.
    Martinelli, V.
    Comi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 351 - 351
  • [8] Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
    Radaelli, M.
    Moiola, L.
    Sangalli, F.
    Esposito, F.
    Barcella, V.
    Ferre, L.
    Rodegher, M.
    Colombo, B.
    Fazio, R.
    Martinelli, V.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (04) : 511 - 519
  • [9] A meta-analysis on efficacy and safety of rituximab for neuromyelitis optica spectrum disorders
    Dong, Gu-Yi
    Meng, Yan-Hong
    Xiao, Xiang-Jian
    MEDICINE, 2022, 101 (36) : E30347
  • [10] Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders
    Ip, Vincent H. L.
    Lau, Alexander Y. L.
    Au, Lisa W. C.
    Fan, Florence S. Y.
    Chan, Anne Y. Y.
    Mok, Vincent C. T.
    Wong, Ka-sing Lawrence
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 324 (1-2) : 38 - 39
12345